Aristotle Capital Boston’s Guardian Pharmacy Services GRDN Stock Holding History

Aristotle Capital Boston’s Portfolio GRDN Stock Details GRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.7M	Sell	422,427 -73,429	-15%	-$2.84M	1.19%	36
2026 Q1	$18.7M	Sell	495,856 -93,159	-16%	-$3.04M	1.16%	28
2025 Q4	$17.7M	Sell	589,015 -60,448	-9%	-$1.71M	0.97%	41
2025 Q3	$17M	Buy	649,463 +239,790	+59%	+$5.71M	0.88%	46
2025 Q2	$8.73M	Buy	+409,673	New	+$9.24M	0.44%	83

Other funds holding GRDN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

VCM

Valiant Capital Management San Francisco, California $2.48B AUM 57.08% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Aristotle Capital Boston's GRDN Position: Q2 2026 in Review

Aristotle Capital Boston reduced its Guardian Pharmacy Services (GRDN) stake by 15% in Q2 2026, selling an estimated $2.84M and leaving 422,427 shares worth $17.7M. The position accounts for 1.19% of the portfolio, ranked #36.

Aristotle Capital Boston first reported a position in GRDN in Q2 2025 and has held it in 5 quarters since. The position peaked at $18.7M in Q1 2026. 190 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

Aristotle Capital Boston held 422,427 shares of Guardian Pharmacy Services worth $17.7M as of Q2 2026.
Aristotle Capital Boston sold 73,429 Guardian Pharmacy Services shares in Q2 2026, an estimated $2.84M.
Guardian Pharmacy Services made up 1.19% of Aristotle Capital Boston's portfolio in Q2 2026, its #36 holding.
Aristotle Capital Boston first reported a position in Guardian Pharmacy Services in Q2 2025 and has held it in 5 quarters since.
Aristotle Capital Boston's Guardian Pharmacy Services position peaked at $18.7M in Q1 2026.
190 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Aristotle Capital Boston's 13F filing for Q2 2026, filed 14 Aug 2026.